HC Wainwright Lowers Plus Therapeutics (NASDAQ:PSTV) Price Target to $2.00
HC Wainwright decreased their price objective on Plus Therapeutics from $3.00 to $2.00 and set a “buy” rating on the stock in a report on Monday.
Source link
Similar Posts
China imposes export ban on companies tied to Taiwan’s military
TAIPEI, Taiwan (AP) — China imposed export controls Wednesday on eight companies tied to Taiwan’s military as the self-ruled island started annual military exercises. China’s Commerce Ministry added eight Taiwan-based firms including aerospace and shipbuilding companies, to an export control list, citing national and regional security concerns. Get stock market alerts: Sign Up The banned…
Trump Tariffs: 3 TSX Stocks That Could Take a Beating
Image source: Getty Images As Canadians, we’ve all experienced the ripple effects of U.S. policies, from trade deals to tariff wars. United States president Donald Trump’s tariff policies have historically disrupted trade between Canada and the United States. Now, as the threat of such tariffs looms again, Canadian businesses could face new challenges. While some…
Stock Market Sell-Off: 3 Stocks I’m Still Buying Now
The Toronto Stock Exchange notched a new record high to start March 2026, despite a revived military conflict in the Middle East over the weekend. However, the breakout performance was short-lived. The sharp, war-driven market sell-off that followed on Tuesday, March 3, saw the TSX plunge 756 points or 2.2%. During this heightened volatility, including…
